Candidal infections in the immunocompromised cancer patient Journal Article

  


Authors: Koll, B. S.; Armstrong, D.
Article Title: Candidal infections in the immunocompromised cancer patient
Abstract: Yeast infections, primarily from Candida species, account for most of the morbidity and mortality from infectious diseases in neutropenic cancer patients. Changes in cancer treatment and prophylaxis account for this increase. Improvements in antifungal treatment have begun to reduce the risks from candidal infections.
Keywords: clinical feature; antifungal agent; short survey; ketoconazole; immune deficiency; fluconazole; candidiasis; itraconazole; flucytosine; nystatin; amphotericin b; clotrimazole; cancer; human
Journal Title: Infections in Medicine
Volume: 10
Issue: 2
ISSN: 0749-6524
Publisher: SCP Communications  
Date Published: 1993-02-01
Start Page: 12, 15
Language: English
PROVIDER: scopus
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-0027256839&partnerID=40&md5=99f36230d844f4749f9b30a58f09e43f
Notes: Short Survey -- Export Date: 1 March 2019 -- Source: Scopus